StockSignal
Penumbra Inc.
PEN · ARCX · Medical Devices · United States
Market Capitalization13.19B USD
Trailing P/E74.14 USD
52-Week Change14.61 USD
Beta0.8360 USD
Penumbra Inc. is a prominent player in the healthcare sector, focusing primarily on the development and commercialization of innovative medical devices. Known for its customer-centric approach, the company operates within the specialized field of interventional therapies, particularly in neuro and vascular medical devices. Penumbra’s products are crucial for addressing critical conditions such as stroke and peripheral artery diseases. By pioneering minimally invasive solutions, the company significantly contributes to enhancing patient outcomes and reshaping intervention methods in the medical field. Founded in 2004 and headquartered in Alameda, California, Penumbra plays a vital role in the medical device industry with its commitment to advancing healthcare technologies. Its solutions are not only pivotal in specialized medical procedures but also support the healthcare ecosystem's broader objective of improving care and saving lives, making it a key entity amongst healthcare providers and hospitals worldwide.
Industry
Medical Devices
Healthcare sector · United States
Stories
Structural patterns identified in Penumbra Inc.
No stories identified yet.
Key Metrics
Market Capitalization
13.19BUSDTrailing P/E
74.14USDRevenue (TTM)
1.40BUSDProfit Margin
12.66%Beta
0.8360USD52-Week Change
14.61USDThis company does not currently pay dividends.
Valuation9
Market Capitalization
13.19BUSDEnterprise Value
12.85BUSDTrailing P/E
74.14USDForward P/E
52.37USDPEG Ratio
1.98USDPrice to Sales (TTM)
9.39USDPrice to Book (MRQ)
9.23USDEnterprise to Revenue
9.16USDEnterprise to EBITDA
62.24USDProfitability & Growth54
Gross Margin
68.02%Profit Margin
12.66%Operating Margin
15.37%Return on Assets (TTM)
0.0704USDReturn on Equity (TTM)
0.1378USDRevenue (TTM)
1.40BUSDRevenue per Share (TTM)
36.07USDQuarterly Revenue Growth
0.2210USDGross Profit (TTM)
942.44MUSDEBITDA
223.91MUSDNet Income (TTM)
177.69MUSDQuarterly Earnings Growth (YoY)
0.4060USDOperating Cash Flow (TTM)
238.66MUSDLevered Free Cash Flow (TTM)
92.69MUSDTrailing Annual Dividend Rate
0.00USDTrailing Annual Dividend Yield
0.00%Payout Ratio
0.00USDRevenue
1.40BCost of Goods Sold
461.23MGross Profit
942.44MOperating Income
189.25MPre-tax Income
205.13MIncome Tax Expense
27.44MNet Income
177.69MEBIT
206.44Mebitda-income
223.91MResearch & Development
89.77MSelling, General & Administrative
663.42MNon-operating Interest Income
16.29MNon-operating Interest Expense
1.31MEPS (Basic)
4.57EPS (Diluted)
4.52Basic Shares Outstanding
38.92MSharesDiluted Shares Outstanding
38.92MSharesNet Income from Continuing Operations
177.69MOperating Cash Flow
232.68MFree Cash Flow
174.93MCash & Cash Equivalents (End of Period)
186.90MNet Income (CF Statement)
177.69MDepreciation & Amortization
17.47MDeferred Taxes (CF)
21.03MStock-based Compensation
59.21MOther Non-cash Items
205.00KChange in Accounts Receivable (CF)
-19.51MChange in Accounts Payable (CF)
3.07MChange in Other Assets/Liabilities
-26.48MCapital Expenditures
-63.73MPurchase of Investments
-355.74MSale of Investments
14.88MNet Investing Cash Flow
-404.59MLong-term Debt Payments
-2.48MCommon Stock Repurchase
0.00Other Financing Charges
-2.80MNet Financing Cash Flow
-5.29MFinancial Strength30
Shares Outstanding
39.23MSharesFloat Shares
38.05MUSDShares Short
1.87MSharesShort Ratio
2.14USDShort % of Shares Outstanding
0.0663USD% Held by Insiders
0.0301USD% Held by Institutions
0.9554USDTotal Cash (MRQ)
544.82MUSDTotal Cash per Share (MRQ)
13.88USDTotal Debt (MRQ)
219.70MUSDTotal Debt to Equity (MRQ)
15.39USDCurrent Ratio (MRQ)
6.64USDBook Value per Share (MRQ)
36.39USDTotal Assets
1.83BTotal Current Assets
1.22BTotal Liabilities
398.92MTotal Non-current Assets
609.84MTotal Non-current Liabilities
215.78MTotal Current Liabilities
183.13MCash & Cash Equivalents
186.90MOther Short-term Investments
357.92MAccounts Receivable
190.02MInventory
431.55MAccounts Payable
34.74MShort-term Debt
16.23MLong-term Debt
203.47MOther Non-current Liabilities
12.32MCommon Stock (Book)
39.00KRetained Earnings
237.69MTotal Shareholders' Equity
1.43BMarket & Technical10
52-Week Low
221.26USD52-Week High
362.41USD52-Week Change
14.61USDBeta
0.8360USD50-Day MA
341.27USD200-Day MA
283.75USDAvg 10-Day Volume
577.53KUSDAvg 30-Day Volume
649.98KUSDDiluted EPS (TTM)
4.53USDOther Income / Expense
893.00KCoordination
Placeholder CorpCoordination
Example HoldingsCoordination
Sample IncCoordination